SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $4,050,000 | +27.1% | 20,696 | +10.3% | 0.01% | +25.0% |
Q2 2020 | $3,187,000 | +64.9% | 18,757 | +11.9% | 0.01% | +33.3% |
Q1 2020 | $1,933,000 | -19.8% | 16,756 | -20.5% | 0.01% | +50.0% |
Q4 2019 | $2,409,000 | +55.5% | 21,083 | +16.2% | 0.00% | +33.3% |
Q3 2019 | $1,549,000 | -34.8% | 18,145 | -47.1% | 0.00% | +200.0% |
Q2 2019 | $2,374,000 | +60.6% | 34,300 | +69.9% | 0.00% | -50.0% |
Q1 2019 | $1,478,000 | +74.3% | 20,185 | +34.8% | 0.00% | +100.0% |
Q4 2018 | $848,000 | -58.9% | 14,969 | -44.0% | 0.00% | -75.0% |
Q3 2018 | $2,063,000 | +47.8% | 26,753 | +27.3% | 0.00% | +33.3% |
Q2 2018 | $1,396,000 | +257.9% | 21,019 | +182.1% | 0.00% | +200.0% |
Q1 2018 | $390,000 | +23.4% | 7,450 | +26.2% | 0.00% | 0.0% |
Q4 2017 | $316,000 | +37.4% | 5,901 | +39.9% | 0.00% | 0.0% |
Q3 2017 | $230,000 | +265.1% | 4,219 | +244.4% | 0.00% | – |
Q2 2017 | $63,000 | -7.4% | 1,225 | +12.9% | 0.00% | – |
Q1 2017 | $68,000 | +51.1% | 1,085 | +26.5% | 0.00% | – |
Q4 2016 | $45,000 | – | 858 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |